S. 1903 · 109th Congress
Generic Prescription Drug Fairness Act of 2005
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
RockefellerSponsor3 cosponsors · 1 D, 2 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Generic Prescription Drug Fairness Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to revise requirements for drug manufacturer reports to the Secretary of Health and Human Services on the average manufacturer price for each covered outpatient drug and the manufacturer's best price for single source and innovator multiple source drugs.
What it does: CRS summary · Introduced in Senate · Oct 20, 2005
Generic Prescription Drug Fairness Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to revise requirements for drug manufacturer reports to the Secretary of Health and Human Services on the average manufacturer price for each covered outpatient drug and the manufacturer's best price for single source and innovator multiple source drugs. Requires manufacturers to report also on the manufacturer's best price for each authorized generic drug and any other drugs sold under a new drug application approved under the Federal Food, Drug, and Cosmetic Act.
Applies the basic rebate for single source and innovator multiple source drugs to authorized generic drugs and any other drugs sold under an approved new drug application.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Generic Prescription Drug Fairness Act of 2005
Latest action (Oct 20, 2005): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Oct 20, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.